Imunon, Inc. (IMNN) income statement
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.58−0.03 (-5.26%)
Close on Nov 18, 2026Market cap $3.25MP/E –Yield –
Imunon, Inc. income statement
Ratios
Latest available, balances at Mar 31, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -256.4%
Financial strength
- Current ratio
- 1.59
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 115.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.97
- Dividend yield
- –
See a number that looks wrong?